Study suggests glaucoma may be an autoimmune disease
Unexpected findings show that the body’s own immune system destroys retinal cells.
Unexpected findings show that the body’s own immune system destroys retinal cells.
With new method, surgeons would remove tumor, then implant microparticles that attack remaining cancer cells.
Faculty members recognized for excellence via a diverse array of honors, grants, and prizes over the last quarter.
Polymeric nanoparticles can efficiently administer mRNA to cells of the lungs, liver, and other organs.
Drugs carried in cellular “backpacks” help T cells to destroy tumors.
MIT researchers develop new tools to enable targeted delivery of drugs to deep brain structures through implanted microprobes.
Researchers identify the amino acid aspartate as a metabolic limitation in certain cancers.
Shortfall of digestive enzymes can lead to tissue breakdown in early stages of pancreatic cancer.
Researchers generate an intestinal cell mimic that can be harnessed in studies of diseases such as inflammatory bowel disease.
Institute Professor chosen to help forge connections and identify opportunities for sustained international cooperation.
Scientists leverage one step, unbiased method to characterize the binding preferences of more than 70 human RNA-binding proteins.
New technology could enable remote control of drug delivery, sensing, and other medical applications.
Nanoparticles carrying two drugs can cross the blood-brain barrier and shrink glioblastoma tumors.
MIT faculty members are among 19 top scientists selected from across the nation.
Nanoparticles could offer a new way to help eradicate the disease worldwide.